NextGen Immuno Therapeutics Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$1.13K
- Investors
-
1
NextGen Immuno Therapeutics General Information
Description
Developer of artificial intelligence-powered immune diagnostics designed for early detection and personalized treatment of immune-related diseases. The company offers a software-as-a-service platform integrating multimodal biological and clinical data by delivering biomarker discovery, patient stratification, and drug repurposing capabilities, enabling hospitals, researchers, and pharmaceutical businesses to improve outcomes, reduce complications, and achieve cost-effective precision medicine.
Contact Information
Website
www.nextgenimmuno.comCorporate Office
- Nippongasse 8
- Vienna, 1220
- Austria
Corporate Office
- Nippongasse 8
- Vienna, 1220
- Austria
NextGen Immuno Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 03-Jun-2025 | $1.13K | Completed | Startup |
NextGen Immuno Therapeutics Signals
NextGen Immuno Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| INiTS Universitäres Gründerservice | Accelerator/Incubator |
NextGen Immuno Therapeutics FAQs
-
When was NextGen Immuno Therapeutics founded?
NextGen Immuno Therapeutics was founded in 2025.
-
Where is NextGen Immuno Therapeutics headquartered?
NextGen Immuno Therapeutics is headquartered in Vienna, Austria.
-
What is the size of NextGen Immuno Therapeutics?
NextGen Immuno Therapeutics has 5 total employees.
-
What industry is NextGen Immuno Therapeutics in?
NextGen Immuno Therapeutics’s primary industry is Other Healthcare Technology Systems.
-
Is NextGen Immuno Therapeutics a private or public company?
NextGen Immuno Therapeutics is a Private company.
-
What is NextGen Immuno Therapeutics’s current revenue?
The current revenue for NextGen Immuno Therapeutics is .
-
How much funding has NextGen Immuno Therapeutics raised over time?
NextGen Immuno Therapeutics has raised $1.13K.
-
Who are NextGen Immuno Therapeutics’s investors?
INiTS Universitäres Gründerservice has invested in NextGen Immuno Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process